THERMO CARDIOSYSTEMS HEARTMATE IS FIRST IMPLANTABLE CARDIAC ASSIST DEVICE
This article was originally published in The Gray Sheet
Executive Summary
THERMO CARDIOSYSTEMS HEARTMATE IS FIRST IMPLANTABLE CARDIAC ASSIST DEVICE commercially available in the U.S. The firm reported Oct. 3 that FDA approved its premarket approval application for the implantable pneumatic left ventricular assist system (LVAS) for use as a bridge to heart transplant. The device is Thermo Cardiosystems' first commercially available product in the U.S.